4//SEC Filing
Cormorant Asset Management, LP 4
Accession 0000929638-25-001950
CIK 0001637715other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 5:33 PM ET
Size
14.4 KB
Accession
0000929638-25-001950
Insider Transaction Report
Form 4
Chen Bihua
10% Owner
Transactions
- Sale
Class A Common Stock
2025-05-15$1.85/sh−1,813,439$3,363,023→ 0 total(indirect: See Footnote)
Cormorant Asset Management, LLC
10% Owner
Transactions
- Sale
Class A Common Stock
2025-05-15$1.85/sh−1,813,439$3,363,023→ 0 total(indirect: See Footnote)
Transactions
- Sale
Class A Common Stock
2025-05-15$1.85/sh−1,813,439$3,363,023→ 0 total(indirect: See Footnote)
Transactions
- Sale
Class A Common Stock
2025-05-15$1.85/sh−1,813,439$3,363,023→ 0 total(indirect: See Footnote)
Transactions
- Sale
Class A Common Stock
2025-05-15$1.85/sh−1,813,439$3,363,023→ 0 total(indirect: See Footnote)
Transactions
- Sale
Class A Common Stock
2025-05-15$1.85/sh−1,813,439$3,363,023→ 0 total(indirect: See Footnote)
Footnotes (2)
- [F1]Cormorant Asset Management, LP serves as the investment manager to Cormorant Global Healthcare Master Fund, LP (the "Master Fund"), Cormorant Private Healthcare Fund III, LP ("Fund III"), Cormorant Private Healthcare Fund IV, LP ("Fund IV") and Cormorant Private Healthcare Fund V, LP ("Fund V"). Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare GP III, LLC, Cormorant Private Healthcare GP IV, LLC and Cormorant Private Healthcare GP V, LLC serve as the general partners of the Master Fund, Fund III, Fund IV and Fund V, respectively. Bihua Chen serves as the managing member of Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare GP III, LLC, Cormorant Private Healthcare GP IV, LLC and Cormorant Private Healthcare GP V, LLC, and the general partner of Cormorant Asset Management, LP.
- [F2]Represents the weighted average sale price of Class A Common Stock (the "shares") sold in a series of open market transactions on the transaction date ranging from $1.85 to $2.03 per share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
Documents
Issuer
OnKure Therapeutics, Inc.
CIK 0001637715
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001583977
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 5:33 PM ET
- Size
- 14.4 KB